The proportion of all NK cell subsets as well as the mean fluorescence intensity values (mfi) of CD94 (69 vs. 43), CD69 (43 vs. 39), and CD56 (70 vs. 40) were higher in a grade IV glioma patient compared to a healthy control, respectively. This evidence concerns the gene NCAM1 and central nervous system cancer.